.

Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
AstraZeneca
Daiichi Sankyo
Mallinckrodt
UBS
QuintilesIMS
Harvard Business School
Baxter
Cipla
Healthtrust

Generated: June 25, 2017

DrugPatentWatch Database Preview

NORTHERA Drug Profile

« Back to Dashboard

Which patents cover Northera, and when can generic versions of Northera launch?

Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.

The generic ingredient in NORTHERA is droxidopa. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the droxidopa profile page.

Summary for Tradename: NORTHERA

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Bulk Api Vendors: see list38
Clinical Trials: see list12
Patent Applications: see list811
Drug Prices:see details
DailyMed Link:NORTHERA at DailyMed

Pharmacology for Tradename: NORTHERA

Ingredient-typeCatecholamines
Physiological EffectIncreased Blood Pressure
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd
NORTHERA
droxidopa
CAPSULE;ORAL203202-001Feb 18, 2014RXYesNo► Subscribe► Subscribe
Lundbeck Na Ltd
NORTHERA
droxidopa
CAPSULE;ORAL203202-002Feb 18, 2014RXYesNo► Subscribe► Subscribe
Lundbeck Na Ltd
NORTHERA
droxidopa
CAPSULE;ORAL203202-001Feb 18, 2014RXYesNo► Subscribe► Subscribe
Lundbeck Na Ltd
NORTHERA
droxidopa
CAPSULE;ORAL203202-002Feb 18, 2014RXYesNo► Subscribe► Subscribe
Lundbeck Na Ltd
NORTHERA
droxidopa
CAPSULE;ORAL203202-003Feb 18, 2014RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Novartis
Julphar
Covington
Cerilliant
Deloitte
Chubb
Federal Trade Commission
US Department of Justice
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot